Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

January 19, 2022
Open Access

Enlarging Liver Mass: Inflammatory Pseudotumor in a Patient With Polymyalgia Rheumatica.

Journal of Investigative Medicine High Impact Case Reports
Gowthami KanagalingamSavio John
January 19, 2022

Glutamine Regulates Skeletal Muscle Immunometabolism in Type 2 Diabetes.

Diabetes
Lucile DolletAnna Krook
January 18, 2022

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.

European Journal of Endocrinology
Charlotte J GreenLeanne Hodson
January 17, 2022

Morphological alteration of the pancreatic islet in ovariectomized rats fed a high-fat high-fructose diet.

Histochemistry and Cell Biology
Piyachat ChanselaVitoon Saengsirisuwan
January 17, 2022

Evidence for a leptin-insulin axis in a fish, the tilapia (Oreochromis mossambicus).

The Journal of Endocrinology
Courtney A DeckRussell J Borski
January 17, 2022

Low-frequency electroacupuncture improves disordered hepatic energy metabolism in insulin-resistant Zucker diabetic fatty rats via the AMPK/mTORC1/p70S6K signaling pathway.

Acupuncture in Medicine : Journal of the British Medical Acupuncture Society
Xiao-Xiao LiuZhi-Xing Li
January 17, 2022

Insulin-GLP-1 receptor agonist relay and GLP-1 receptor agonist first regimens in individuals with type 2 diabetes: a randomized, open-label trial study.

Journal of Diabetes Investigation
Yumie TakeshitaEstablishment of Rationale for Antiaging Diabetic Medicine (ERA-DM) Study Group
January 16, 2022

Decoding the role of macrophages in periodontitis and type 2 diabetes using single-cell RNA-sequencing.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Panagiota AgrafiotiFatemeh Momen-Heravi
January 16, 2022
Preprint
Open Access

Estimating body fat distribution - a driver of cardiometabolic health - from silhouette images

MedRxiv : the Preprint Server for Health Sciences
M. D. R. KlarqvistAmit V. Khera
January 15, 2022
Preprint
Open Access

Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy

MedRxiv : the Preprint Server for Health Sciences
Y. YangSong-Mei Liu
January 15, 2022
Open Access

Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus.

Frontiers in Endocrinology
Sabaa JoadReina Armamento-Villareal

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2022 Meta ULC. All rights reserved
/feed-previews/biomarkers-for-type-2-diabetes/96a56e2d-18c4-4ec1-a700-d64be2f4efb1